Navigation Links
New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments
Date:9/2/2010

nd regenerative medicine company, and Medistem, Inc. (Pink Sheets: MEDS; http://www.medisteminc.com ), reported positive safety data in 114 patients who were treated by doctors at Nanshan Affiliated Hospital of Guangdong Medical College (Shenzhen Nanshan Hospital) in Shenzhen using Beike's proprietary cord blood stem cell transplantation protocol.

The peer-reviewed paper is available at http://bit.ly/cBNBYt .

The report aims to serve as an "expanded Phase I" study, with efficacy data to be published in a subsequent paper. It describes biochemical, hematological, immunological, and general safety profiles of patients with neurological diseases who were observed from between one month to four years after treatment. No serious treatment-associated adverse effects were observed.

Dr. Wanzhang Yang, who led the study at Nanshan Affiliated Hospital of Guangdong Medical College commented, "This important study, which is the largest of its kind, demonstrates the safety and efficacy of using cord-blood-derived stem cells to treat a variety of neurological conditions. However, it also suggests cord-blood-derived stem cells are a safe and viable treatment option for a much broader range of diseases and conditions than previously thought."

Because the protocol developed by Beike allows the use of cord blood stem cells without immune suppression, it can be made available to a wide patient population. Until now, patients receiving cord blood transplants to fight hematopoietic diseases were immune-suppressed in order to prevent a potentially devastating condition known as "graft versus host." This new research challenges the necessity of that practice.

Medistem CEO Thomas Ichim stated, "It is an honor to collaborate with Beike on this seminal publication. The fact that Beike has been able to demonstrate safety of transplant by manipulating an established stem cell sou
'/>"/>

SOURCE Shenzhen Beike Biotechnology Company, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells
2. PharmaNet Development Group Appoints Anthony Maida, Vice President, Clinical Research
3. SU research team uses nanobiotechnology-manipulated light particles to accelerate algae growth
4. BioFortis and Catholic Health Initiatives Center for Translational Research Announce Biorepository Information Technology Strategic Partnership to Drive Progress in Personalized Medicine
5. Castor Bean Genome Published by Research Team Including Scientists from the Venter Institute
6. US Oncology Helps Deliver Latest Cancer Therapies Through Local Community Access to Cutting Edge Research
7. Researchers stretch a lackluster material into a possible electronics revolution
8. ASU industry research consortium poised to expand
9. MabVax Therapeutics Receives Small Business Innovation Research Program Award from the National Cancer Institute
10. K-State Research Team Investigates Mutated Genes Role in Breast Cancer
11. Researchers successfully test new alternative to traditional semiconductors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 Kitware, a leader ... tool that enables the exploration of hospital costs ... in response to the recent release of “Medicare Provider ... top 100 most-billed procedures from the Centers for Medicare ... for similar procedures at hospitals across the country has ...
(Date:5/17/2013)... May 17, 2013 Topricin Pain ... Inc., has been listed among nationally recommended over-the-counter ... initiative conducted by "U.S. News" Health in collaboration ... the “No. 1 Pharmacists Recommended designation” in ... national OTC brands, and is the only homeopathic ...
(Date:5/17/2013)... world-leading provider of scientific, technical and medical information products ... study in Reproductive BioMedicine Online ... an abnormal chromosomal composition can be identified by the ... classifying the risk of genetic abnormality without a biopsy. ... a retrospective study, using their predictive model to assess ...
(Date:5/17/2013)... , May 17, 2013  Yongye International, Inc. (NASDAQ: ... leading developer, manufacturer, and distributor of crop nutrient products ... , today announced that, on May 16, 2013, the ... directors (the "Board of Directors") was provided a letter ... Hong Kong ) Limited ("Abax") to Full Alliance ...
Breaking Biology Technology:Kitware Enables Interactive Exploration of CMS Medicare Data 2Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products 2Breakthrough for IVF? 2Breakthrough for IVF? 3Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4
... FRANCISCO, Feb. 14 BioSpace, the world,s ... announced today the,expansion of its reach to ... by its parent company, onTargetjobs. With the,inclusion ... Internet job boards, BioSpace now offers biotechnology,pharmaceutical, ...
... Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ANP), ... today announced unaudited interim and annual,consolidated financial ... ended,December 31, 2007. The unaudited financial results ... as described under the section "Financial,Information"., ...
... Provides Full Year 2008 Revenue Guidance of $350 million ... Symmetry Medical Inc.,(NYSE: SMA ), an independent provider ... medical markets, today reported preliminary,fourth quarter 2007 revenue of ... not be reported at this time., As previously ...
Cached Biology Technology:BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition 2BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition 3Angiotech announces results for the fourth quarter ended December 31, 2007 2Angiotech announces results for the fourth quarter ended December 31, 2007 3Angiotech announces results for the fourth quarter ended December 31, 2007 4Angiotech announces results for the fourth quarter ended December 31, 2007 5Angiotech announces results for the fourth quarter ended December 31, 2007 6Angiotech announces results for the fourth quarter ended December 31, 2007 7Angiotech announces results for the fourth quarter ended December 31, 2007 8Angiotech announces results for the fourth quarter ended December 31, 2007 9Angiotech announces results for the fourth quarter ended December 31, 2007 10Angiotech announces results for the fourth quarter ended December 31, 2007 11Angiotech announces results for the fourth quarter ended December 31, 2007 12Angiotech announces results for the fourth quarter ended December 31, 2007 13Angiotech announces results for the fourth quarter ended December 31, 2007 14Angiotech announces results for the fourth quarter ended December 31, 2007 15Angiotech announces results for the fourth quarter ended December 31, 2007 16Angiotech announces results for the fourth quarter ended December 31, 2007 17Angiotech announces results for the fourth quarter ended December 31, 2007 18Angiotech announces results for the fourth quarter ended December 31, 2007 19Angiotech announces results for the fourth quarter ended December 31, 2007 20Angiotech announces results for the fourth quarter ended December 31, 2007 21Angiotech announces results for the fourth quarter ended December 31, 2007 22Angiotech announces results for the fourth quarter ended December 31, 2007 23Angiotech announces results for the fourth quarter ended December 31, 2007 24Symmetry Medical Reports Preliminary Fourth Quarter Revenue 2Symmetry Medical Reports Preliminary Fourth Quarter Revenue 3Symmetry Medical Reports Preliminary Fourth Quarter Revenue 4
(Date:5/20/2013)... that a compound abundant in the Mediterranean diet takes ... By altering a very specific step in gene regulation, ... that die as scheduled. , One way that cancer ... cause them to die on a regular cycle that ... led by Ohio State University researchers, found that a ...
(Date:5/20/2013)... of Bristol and published online today in the ... the brain and inner ear developed in dinosaurs. ... together with Tom Hbner from the Niederschsische Landesmuseum in ... old dinosaurs. , The two palaeontologists studied different fossils ... very young (juvenile) individual of approximately three years ...
(Date:5/19/2013)... that can grow using hydrogen gas as its sole ... of carbon. Researchers at the University of Massachusetts, ... of the American Society for Microbiology. , "This represents ... says Amit Kumar, a researcher on the study who, ... Lab Group at the university. , Under the leadership ...
Breaking Biology News(10 mins):The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3Fossil brain teaser 2
... ANN ARBOR, Mich.---An international team co-led by scientists from ... the genome with DNA variants that are associated with increased ... A variant is a place on a string of ... people. At most places along the DNA, any two people ...
... , VILLINGEN-SCHWENNINGEN, Germany , June 30 Multicard ... INV) and an identity management systems integrator and solutions provider, announced ... Secure IT kits has been selected under the new electronic identification ... ("Bundesministerium des Innern"). , , ...
... dramatic new real-world evidence supporting the idea that hand ... appears in a new study showing a connection between ... drinking water, and health in households in a developing ... Environmental Science & Technology , a semi-monthly journal. ...
Cached Biology News:New variants found that indicate a predisposition to type 2 diabetes 2Multicard to Supply Secure IT Kits Under German Federal Government's Electronic ID Program 2Multicard to Supply Secure IT Kits Under German Federal Government's Electronic ID Program 3
PEG 8000 is used in the precipitation of phage, isolation of plasmid DNA and the enhancement of blunt-ended ligation reactions....
Recombinant Mouse Matrilin-4, CF Protein Family: Extracellular Matrix Molecules, Chondrogenesis Markers...
... all types of yeast two-hybrid studies, including complex interaction ... Choice of two bait vectors for maximum flexibility ... Triple reporter strain NMY51 ensures ... Complete set of controls: pLexA-p53, pLexA-lamin C ...
PlusOne EDTA, disodium salt, 100 g. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Buffers....
Biology Products: